Provided by Tiger Fintech (Singapore) Pte. Ltd.

IO Biotech, Inc.

1.48
-0.0700-4.52%
Post-market: 1.45-0.0291-1.97%19:07 EDT
Volume:180.01K
Turnover:270.58K
Market Cap:97.50M
PE:-0.99
High:1.60
Open:1.56
Low:1.45
Close:1.55
Loading ...
Apr 14, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2022

Major Issues Report

8-K - Current report
Mar 03, 2022

Major Issues Report

8-K - Current report
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 17, 2021

Major Issues Report

8-K - Current report
Dec 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 06, 2021

Major Issues Report

8-K - Current report
Nov 19, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Nov 19, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Nov 05, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 01, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 26, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933